CorMedix shareholders reject five of eight proposals at 2026 annual meeting

CorMedix Inc.

All eight director nominees elected with over 33M votes each; broker non-votes ~20M.
Advisory say-on-pay and auditor ratification approved with ~73% and 97% of votes cast respectively.
Proposal to ratify COD Amendments (Proposal 4) not approved: 37.3M for, 3.2M against, plus 20M broker non-votes.
Proposals 5-8 (charter amendments, class voting, exclusive forum, officer liability) all failed to pass.
Management's proposed governance changes were largely rejected by shareholders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.